MAM
RVMD icon

McCarthy Asset Management’s Revolution Medicines RVMD Stock Holding History

McCarthy Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,300
Closed -$41K – 377
2021
Q2 		$41K Hold
1,300
– – 0.03% 107
2021
Q1 		$60K Hold
1,300
– – 0.05% 82
2020
Q4 		$51K Buy
+1,300
New +$51.4K 0.04% 85

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McCarthy Asset Management's RVMD Position: Q3 2021 in Review

McCarthy Asset Management sold out of Revolution Medicines (RVMD) in Q3 2021, closing a stake of 1,300 shares — an estimated $41K sold.

McCarthy Asset Management first reported a position in RVMD in Q4 2020 and held it in 3 quarters. The position peaked at $60K in Q1 2021. 114 funds tracked by Wall St. Rank hold RVMD as of Q3 2021.

  • McCarthy Asset Management reported no remaining Revolution Medicines position as of Q3 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 1,300 Revolution Medicines shares in Q3 2021, an estimated $41K.
  • McCarthy Asset Management first reported a position in Revolution Medicines in Q4 2020 and held it in 3 quarters.
  • McCarthy Asset Management's Revolution Medicines position peaked at $60K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2021.

Based on McCarthy Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.